NCT06713824Active, not recruiting
Neoadjuvant Radiotherapy Before Surgery for Rectal Cancer, Surgical and Oncological Outcome Analysis, Retrospective Case Control Study in a Single Institute.
Source: ClinicalTrials.gov · Last updated 3 Dec 2024
Brief summary (registry, in English)
Pre-operative radiotherapy for clinical stage 3 rectal cancer outcome analysis, retrospective case-control study.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 28 Nov 2024
- Start date
- 1 Jan 2017
- Primary completion date
- 1 Oct 2024
- Lead sponsor
- Taichung Veterans General Hospital
- Diseases
- Colorectal cancer
- NCT number
- NCT06713824
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Jan 2017 to the primary completion date, 1 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Non-rectal cancer.
- HIV-positive patients (Human Immunodeficiency Virus).
Age
- Age \< 20 years, ASA class IV-V.
Other
- Clinical stage T1-T2.
- Stage IV with distant metastasis.
- Incomplete medical records.
- Patients who completed treatment after October 1, 2024.
Who the study is looking for
- Rectal cancer, clinical stage T3 or higher, with no distant metastasis.
- Age \> =20 years, ASA class I-III.
- Underwent surgery.
- Complete medical records.
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Taichung Veterans General Hospital Coordinator of this site? Confirm its status | Taichung | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.